Wigzell Hans Lennart Rudolf - Net Worth and Insider Trading

Wigzell Hans Lennart Rudolf Net Worth

The estimated net worth of Wigzell Hans Lennart Rudolf is at least $3 Million dollars as of 2024-12-28. Wigzell Hans Lennart Rudolf is the Director of Sarepta Therapeutics Inc and owns about 22,840 shares of Sarepta Therapeutics Inc (SRPT) stock worth over $3 Million. Details can be seen in Wigzell Hans Lennart Rudolf's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wigzell Hans Lennart Rudolf has not made any transactions after 2024-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Wigzell Hans Lennart Rudolf

Wigzell Hans Lennart Rudolf Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Wigzell Hans Lennart Rudolf owns 1 companies in total, including Sarepta Therapeutics Inc (SRPT) .

Click here to see the complete history of Wigzell Hans Lennart Rudolf’s form 4 insider trades.

Insider Ownership Summary of Wigzell Hans Lennart Rudolf

Ticker	Comapny	Transaction Date	Type of Owner
SRPT	Sarepta Therapeutics Inc	2024-12-12	director

Wigzell Hans Lennart Rudolf Latest Holdings Summary

Wigzell Hans Lennart Rudolf currently owns a total of 1 stock. Wigzell Hans Lennart Rudolf owns 22,840 shares of Sarepta Therapeutics Inc (SRPT) as of December 12, 2024, with a value of $3 Million.

Latest Holdings of Wigzell Hans Lennart Rudolf

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
SRPT	Sarepta Therapeutics Inc	2024-12-12	22,840	121.50	2,775,060

Holding Weightings of Wigzell Hans Lennart Rudolf

Wigzell Hans Lennart Rudolf Form 4 Trading Tracker

According to the SEC Form 4 filings, Wigzell Hans Lennart Rudolf has made a total of 7 transactions in Sarepta Therapeutics Inc (SRPT) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Sarepta Therapeutics Inc is the sale of 10,500 shares on December 12, 2024, which brought Wigzell Hans Lennart Rudolf around $1 Million.

Insider Trading History of Wigzell Hans Lennart Rudolf

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Wigzell Hans Lennart Rudolf Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Wigzell Hans Lennart Rudolf Ownership Network

Ownership Network List of Wigzell Hans Lennart Rudolf

No Data

Ownership Network Relation of Wigzell Hans Lennart Rudolf

Wigzell Hans Lennart Rudolf Owned Company Details

What does Sarepta Therapeutics Inc do?

Who are the key executives at Sarepta Therapeutics Inc?

Wigzell Hans Lennart Rudolf is the director of Sarepta Therapeutics Inc. Other key executives at Sarepta Therapeutics Inc include Chief Financial Officer Ian Michael Estepan , Chief Tech Ops Officer Bilal Arif , and SVP & General Counsel Ryan Edward Brown .

Sarepta Therapeutics Inc (SRPT) Insider Trades Summary

Over the past 18 months, Wigzell Hans Lennart Rudolf made 3 insider transaction in Sarepta Therapeutics Inc (SRPT) with a net sale of 40,500. Other recent insider transactions involving Sarepta Therapeutics Inc (SRPT) include a net purchase of 105,570 shares made by Michael Andrew Chambers , a net sale of 40,957 shares made by Ryan Edward Brown , and a net sale of 13,757 shares made by Bilal Arif .

In summary, during the past 3 months, insiders sold 12,136 shares of Sarepta Therapeutics Inc (SRPT) in total and bought 0 shares, with a net sale of 12,136 shares. During the past 18 months, 111,566 shares of Sarepta Therapeutics Inc (SRPT) were sold and 180,795 shares were bought by its insiders, resulting in a net purchase of 69,229 shares.

Sarepta Therapeutics Inc (SRPT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sarepta Therapeutics Inc Insider Transactions

No Available Data

Wigzell Hans Lennart Rudolf Mailing Address

Above is the net worth, insider trading, and ownership report for Wigzell Hans Lennart Rudolf. You might contact Wigzell Hans Lennart Rudolf via mailing address: Oskar Baeckstromsv.11, Hagersten V7 12935.

Discussions on Wigzell Hans Lennart Rudolf

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.